Innate apoptosis of human B lymphoblasts transformed by Epstein-Barr virus: Modulation by cellular immortalization and senescence

Cell Structure and Function

Volumn 28, Issue 1, 2003, Pages 61-70

  Satoh, Misako ^a,b   Yasuda, Tomoyoshi ^c   Higaki, Toru ^d   Goto, Makoto ^e   Tanuma, Sei Ichi ^f   Ide, Toshinori ^d   Furuichi, Yasuhiro ^a   Sugimoto, Masanobu ^a  

^a GeneCare Research Institute   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^e Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^f TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Apoptosis B lymphoblasts; Epstein Barr virus; Immortalization; LCLs; Senescence

Indexed keywords

DNA FRAGMENT;

APOPTOSIS; ARTICLE; B LYMPHOBLAST; CELL AGING; CELL CULTURE; CELL IMMORTALIZATION; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CELL SIZE; CELL STRUCTURE; CELL SURVIVAL; CELL TYPE; CHROMATIN CONDENSATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE TRANSFORMATION; PHENOTYPE; PRIORITY JOURNAL;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0346785247     PISSN: 03867196     EISSN: None     Source Type: Journal    
DOI: 10.1247/csf.28.61     Document Type: Article

References (21)

1. Altmeyer, Simmons, A., R.C., Krajewski, S., Reed, J.C., Bornkamm, G.W., and Chen-Kiang, S. 1997. Reversal of EBV immortalization precedes apoptosis in IL-6-inducehuman B cell terminal differentiation. Immunity, 7: 667-677.
2. Arends, M.J., Morris, R.G., and Wyllie, A.H. 1990. Apoptosis. The role of the endonuclease. Am. J. Pathol., 136: 593-608.
3. Beatty, P.R., Krams, S.M., and Martinez, O.M. 1997. Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines. J. Immunol., 158: 4045-4051.
4. Counter, C.M., Avilion, A.A., LeFeuvre, C.E., Stewart, N.G., Greider, C.W., Harley, D.B., and Bacchetti, S. 1992. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11: 1921-1929.
5. Counter, C.M., Botelho, F.M., Wang, P., Harley, C.B., and Bacchetti, S. 1994. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J. Virol., 68: 3410-3414.
6. Darzynkiewics, Z., Li, X., and Gong, J. 1994. Assays of cell viability: discrimination of cells dying by apoptosis. Methods Cell Biol., 41: 15-38.
7. Deininger, P.L., Jolly, D.J., Rubin, C.M., Friedmann, T., and Schmid, C.W. 1981. Base sequence studies of 300 nucleotide renatured repeated human DNA clones. J. Mol. Biol., 151: 17-33.
8. Estrov, Z., Kurzrock, R., Pocsik, E., Pathak, S., Kantarjian, H.M., Zipf, T.F., Harris, D., Talpaz, M., and Aggarwal, B.B. 1993. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus- infected B cell lines. J. Exp. Med, 177: 763-774.
9. Gibbons, D.L., Rowe, M., Cope, A.P., Feldmann, M., and Brennan, F.M. 1994. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines. Eur. J. Immunol., 24: 1879-1885.
10. Kataoka, H., Tahara, H., Watanabe, T., Sugawara, M., Ide, T., Goto, M., Furuichi, Y., and Sugimoto, M. 1997. Immortalization of immunologically committed Epstein-Barr virus-transformed human B-lymphoblastoid cell lines accompanied by a strong telomerase activity. Differentiation, 62: 203-211.
11. Miller, G. 1990. Epstein-Barr virus biology, pathogenesis and medical aspects. In Virology (Fields, B.N., Knipe, K.M. eds.). Raven Press, New York, p. 1921-1958.
12. Morse, L., Chen, D., Franklin, D., Xiong, Y., and Chen-Kiang, S. 1997. Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6. Immunity, 6: 47-56.
13. Nilsson, K. 1979. The nature of lymphoid cell lines and their relationship to the virus. In The Epstein Barr virus (Epstein, M.A., Achong, B.G. eds.). Springer-Verlag, Berlin Heidelberg New York, p. 225-281.
14. Nilsson, K. 1992. Human B-lymphoid cell lines. Hum. Cell, 5: 25-41.
15. Ogburn, C.E., Oshima, J., Poot, M., Chen, R., Hunt, K.E., Gollahon, K.A., Rabinovitch, P.S., and Martin, G.M. 1997. An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants. Hum. Genet., 101: 121-125.
16. Okada, M., Goto, M., Furuichi, Y., and Sugimoto, M. 1998. Differential effects of cytotoxic drugs on mortal and immortalized B-lymphoblastoid cell lines from normal and Werner's syndrome patients. Biol. Pharm. Bull., 21: 235-239.
17. Okubo, M., Tsurukubo, Y., Higaki, T., Kawabe, T., Goto, M., Murase, T., Ide, T., Furuichi, Y., and Sugimoto, M. 2001. Clonal chromosomal aberrations accompanied by strong telomerase activity in immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Genet. Cytogenet., 129: 30-34.
18. Sugimoto, M., Yasuda, T., and Asano, T. 1981. Asymmetric division of lymphoid cells of the thymus of embryonic guinea-pigs. A cell kinetic study. Immunology, 43: 707-715.
19. Sugimoto, M., Ide, T., Goto, M., and Furuichi, Y. 1999a. Incorrect use of "immortalization" for B-lymphoblastoid cell lines transformed by Epstein-Barr virus. J. Virology, 73: 9690-9691.
20. Sugimoto, M., Ide, T., Goto, M., and Furuichi, Y. 1999b. Reconsideration of senescence, immortalization and telomere maintenance of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines. Mech. Ageing Dev., 107: 51-60.
21. Tahara, H., Tokutake, Y., Maeda, S., Kataoka, H., Watanabe, T., Satoh, M., Matsumoto, T., Sugawara, M., Ide, T., Goto, M., Furuichi, Y., and Sugimoto., M. 1997. Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein-Barr virus. Oncogene, 15: 1911-1920.